Ginkgo Bioworks
DNA
DNA
190 hedge funds and large institutions have $2.68B invested in Ginkgo Bioworks in 2022 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 66 increasing their positions, 31 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.44% less ownership
Funds ownership: 1.71% → 1.27% (-0.44%)
30% less call options, than puts
Call options by funds: $23.4M | Put options by funds: $33.5M
64% less capital invested
Capital invested by funds: $7.39B → $2.68B (-$4.71B)
Holders
190
Holding in Top 10
12
Calls
$23.4M
Puts
$33.5M
Top Buyers
| 1 | +$235M | |
| 2 | +$86.1M | |
| 3 | +$42.1M | |
| 4 |
HF
HRT Financial
New York
|
+$30.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$26.4M |
Top Sellers
| 1 | -$1.16B | |
| 2 | -$117M | |
| 3 | -$94M | |
| 4 |
GA
General Atlantic
New York
|
-$83.6M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$37.4M |